Westlake Chemical (NYSE:WLK) reported Q2 EPS of $6.60, $0.52 better than the analyst estimate of $6.08. Revenue for the quarter came in at $4.5 billion versus the consensus estimate of $4.27 billion.
Westlake Chemical (NYSE:WLK) reported Q2 EPS of $6.60, $0.52 better than the analyst estimate of $6.08. Revenue for the quarter came in at $4.5 billion versus the consensus estimate of $4.27 billion.